CCM
SNOA icon

Chilton Capital Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Chilton Capital Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1
Closed -$1.75K – 266
2013
Q4 		$1.75K Hold
1
– – ﹤0.01% 363
2013
Q3 		$1.38K Hold
1
– – ﹤0.01% 380
2013
Q2 		$1K Buy
+1
New +$3.57K ﹤0.01% 381

Other funds holding SNOA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Chilton Capital Management's SNOA Position: Q1 2014 in Review

Chilton Capital Management sold out of Sonoma Pharmaceuticals (SNOA) in Q1 2014, closing a stake of 1 share — an estimated $1.75K sold.

Chilton Capital Management first reported a position in SNOA in Q2 2013 and held it in 3 quarters. The position peaked at $1.75K in Q4 2013. 18 funds tracked by Wall St. Rank hold SNOA as of Q1 2014.

  • Chilton Capital Management reported no remaining Sonoma Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Chilton Capital Management sold 1 Sonoma Pharmaceuticals share in Q1 2014, an estimated $1.75K.
  • Chilton Capital Management first reported a position in Sonoma Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Chilton Capital Management's Sonoma Pharmaceuticals position peaked at $1.75K in Q4 2013.
  • 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2014.

Based on Chilton Capital Management's 13F filing for Q1 2014, filed 12 May 2014.